GTC Biotherapeutics (fka GTCB)

[croumagnon]

Re: Current Insider Shareholdings and Options

The amount of options held by the officers is impressive, especially for Cox. You point out that most of these options are exercisable at a price greater than $1, which is nice to know at this stage...

Regarding that however, what would be required for them to reprice the exercise price of these options downwards? Would they need shareholder approval? Is it easier for them to do so by asking for a Reverse Stock Split and adjusting the option exercise price more radically than the Reverse Stock Split ratio?